Biomarker    C-reactive protein levels and outcomes after statin therapy N Engl J Med (2005);352:20-8 P. M. Ridker, et al. An evolving story of lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular risk prediction Eur Heart J (2005);26:107-9 C. H. Macphee and J. J. Nelson Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg Circulation (2004);109:601-6 D. E. Zylberstein, et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris Circulation (2004);110:1747-53 E. Zouridakis, et al. C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study Heart (2004);90:419-24 M. N. Zairis, et al. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction Chest (2004);126:1417-22 H. K. Yip, et al. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies Eur Heart J (2004);25:1049-56 J. W. Yarnell, et al. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients Eur Heart J (2004);25:2006-12 A. T. Yan, et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis J Am Coll Cardiol (2004);44:1819-24 R. Wolk, et al. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function Circulation (2004);110:1940-5 G. S. Werner, et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein Circulation (2004);109:3164-70 S. Tsimikas, et al. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention Circulation (2004);109:481-6 N. Takamori, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis Circulation (2004);110:1387-91 S. Suzuki, et al. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study Eur Heart J (2004);25:1509-16 J. Sundstrom, et al. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study Circulation (2004);109:2850-6 J. Sundstrom, et al. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials Am Heart J (2004);148:34-40 A. Splaver, et al. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome Heart (2004);90:264-9 P. L. Sanchez, et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation (2004);110:380-5 M. K. Rutter, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes Eur Heart J (2004);25:313-21 M. T. Roe, et al. Renal disease, homocysteine, and cardiovascular complications Circulation (2004);109:294-5 K. Robinson Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes Circulation (2004);110:1586-91 J. Quilici, et al. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women Circulation (2004);110:292-300 A. D. Pradhan, et al. Plasma adiponectin levels and risk of myocardial infarction in men Jama (2004);291:1730-7 T. Pischon, et al. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes Am Heart J (2004);148:776-82 M. X. Pham, et al. Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction J Am Coll Cardiol (2004);43:35-8 G. Patti, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region Circulation (2004);110:2678-86 A. Patel, et al. Inflammatory markers and the risk of coronary heart disease in men and women N Engl J Med (2004);351:2599-610 J. K. Pai, et al. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes Am Heart J (2004);148:405-15 L. Oltrona, et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes Circulation (2004);109:465-70 K. Okamatsu, et al. Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization J Am Coll Cardiol (2004);44:661-6 H. Niiyama, et al. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions Am J Cardiol (2004);93:750-3 M. K. Natarajan, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease Heart (2004);90:528-33 Y. Nakamura, et al. Biomarkers for coronary heart disease: predictive value or background noise? Jama (2004);292:2824-5 M. Mitka B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol (2004);44:335-9 J. L. Mega, et al. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin J Am Coll Cardiol (2004);44:451-7 T. Matsumoto, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction J Am Coll Cardiol (2004);44:1510-20 Y. Maekawa, et al. Leukocyte count and coronary heart disease: implications for risk assessment J Am Coll Cardiol (2004);44:1945-56 M. Madjid, et al. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention Circulation (2004);109:2524-8 H. S. Lim, et al. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein Chest (2004);126:1032-9 H. B. Leu, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients J Am Coll Cardiol (2004);43:958-65 M. C. Kontos, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation (2004);109:726-32 B. D. Johnson, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J Am Coll Cardiol (2004);44:1210-4 A. Jeremias, et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals Am J Cardiol (2004);93:88-90 I. P. Garrido, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes Circulation (2004);110:128-34 M. Galvani, et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE) Am Heart J (2004);147:42-8 M. I. Furman, et al. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease J Am Coll Cardiol (2004);44:44-9 S. Fichtlscherer, et al. C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease Eur Heart J (2004);25:1412-8 S. Fichtlscherer, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J Am Coll Cardiol (2004);44:1812-8 R. Deo, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med (2004);350:1387-97 J. Danesh, et al. Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases Eur Heart J (2004);25:1675-8 J. L. Cracowski and O. Ormezzano Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes Circulation (2004);110:1592-7 L. Bolognese, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper Circulation (2004);110:e560-7 L. M. Biasucci Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study Circulation (2004);109:837-42 C. M. Ballantyne, et al. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study Am Heart J (2004);147:239-45 L. Arcavi, et al. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis Am J Cardiol (2004);93:313-7 A. E. Ajani, et al.